7Baggers
 3 Growth Stocks That Could Be 10-Baggers in 10 Years  AOL.com Fri, 03 Oct 2025 13:05:04 GMT
 Crispr Therapeutics stock hits 52-week high at 71.14 USD By Investing.com  Investing.com Australia Thu, 02 Oct 2025 17:33:24 GMT
 CRISPR Therapies Clinical Trial Pipeline Shows Potential  GlobeNewswire Thu, 02 Oct 2025 17:02:51 GMT
 Genome Editing Market Report 2025: CRISPR and Beyond -  GlobeNewswire Wed, 01 Oct 2025 15:17:57 GMT
 CRISPR Therapeutics to Present Preclinical Data on Alpha-1  GlobeNewswire Wed, 01 Oct 2025 12:03:37 GMT
 Got $200? 2 Healthcare Stocks to Buy and Hold Forever  Yahoo Finance Wed, 01 Oct 2025 09:10:00 GMT
 u.s. gene editing market projections 2025-2032: key trends,  openPR.com Wed, 01 Oct 2025 05:03:59 GMT
 could this beaten-down stock help you become a millionaire?  AOL.com Tue, 30 Sep 2025 14:32:22 GMT
 published on: 2025-09-29 07:23:14  newser.com Mon, 29 Sep 2025 12:23:14 GMT
 published on: 2025-09-29 01:02:34  newser.com Mon, 29 Sep 2025 06:02:34 GMT
 CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why  Yahoo Finance Fri, 26 Sep 2025 21:50:02 GMT
 united states crispr market size, share, growth analysis,  openPR.com Fri, 26 Sep 2025 05:53:54 GMT
 crispr screens pinpoint genetic tweaks that improve car t therapies for multiple myeloma  Genetic Engineering and Biotechnology News Wed, 24 Sep 2025 16:38:59 GMT
 crsp & sirius begin dosing in thromboembolic disorder study in eu  Zacks Investment Research Tue, 23 Sep 2025 15:31:06 GMT
 Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?  Yahoo Finance Tue, 23 Sep 2025 13:00:01 GMT
 crsp stock: hc wainwright reiterates buy rating at $80 | crsp st  GuruFocus Tue, 23 Sep 2025 11:52:14 GMT
 sirius and crispr dose first subject in trial of thromboembolic disorders therapy  Clinical Trials Arena Tue, 23 Sep 2025 08:34:31 GMT
 H.C. Wainwright reiterates Buy rating on CRISPR Therapeutics stock  Investing.com Tue, 23 Sep 2025 07:00:00 GMT
 intellia to present data on crispr therapy for attr amyloidosis by investing.com  Investing.com Canada Mon, 22 Sep 2025 17:56:29 GMT
 crsp advances phase 2 trial for innovative thrombosis treatment  GuruFocus Mon, 22 Sep 2025 13:55:50 GMT
 CRISPR Therapeutics doses first patient in Phase 2 thrombosis trial  Investing.com Mon, 22 Sep 2025 07:00:00 GMT
 Crispr Therapeutics AG Surges Amid Analyst Praise  TipRanks Sat, 20 Sep 2025 07:00:00 GMT
 crispr therapeutics (crsp) gains on j.p. morgan's overweight rat  GuruFocus Thu, 18 Sep 2025 14:32:00 GMT
 crispr stock wins new overweight at j.p. morgan (crsp:nasdaq)  Seeking Alpha Thu, 18 Sep 2025 12:58:19 GMT
 crispr therapeutics initiated with an overweight at jpmorgan  TipRanks Thu, 18 Sep 2025 09:13:47 GMT
 jpmorgan starts crispr therapeutics (crsp) at overweight  StreetInsider Thu, 18 Sep 2025 07:25:28 GMT
 CRISPR Therapeutics stock initiated with Overweight rating by JPMorgan  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 gene editing market exclusive report with detailed study &  openPR.com Wed, 17 Sep 2025 09:11:01 GMT
 crsp stock: how to invest in crispr therapeutics  The Motley Fool Wed, 17 Sep 2025 07:00:00 GMT
 crispr therapy extends survival in mouse models of msmds  Technology Networks Tue, 16 Sep 2025 08:40:45 GMT
 CRISPR Therapeutics (NASDAQ:CRSP) Trading Up 6.8% - Here's Why  MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
 david liu pioneers disease-agnostic gene editing beyond crispr  WebProNews Mon, 15 Sep 2025 17:31:41 GMT
 biomedical crispr gene editing market to see booming growth  openPR.com Mon, 15 Sep 2025 12:49:14 GMT
 three crispr stocks you can’t afford to miss  NAI500 Mon, 15 Sep 2025 03:12:48 GMT
 crispr therapeutics (nasdaq:crsp) shares up 6.8% - should you buy?  MarketBeat Sat, 13 Sep 2025 18:18:53 GMT
 crispr therapeutics (nasdaq:crsp) trading up 6.8% - still a buy?  MarketBeat Sat, 13 Sep 2025 18:18:53 GMT
 Brokerages Set CRISPR Therapeutics AG (NASDAQ:CRSP) PT at $71.60  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 invesco ltd. has $951,000 holdings in crispr therapeutics ag $crsp  MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
 how sentiment analysis helps forecast crispr therapeutics ag  Newser Sat, 06 Sep 2025 08:48:31 GMT
 q1 eps estimate for crispr therapeutics lifted by analyst  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 crispr pipeline outlook 2025: clinical trial studies, ema,  openPR.com Thu, 04 Sep 2025 22:14:04 GMT
 zacks research has optimistic outlook of crsp q1 earnings  MarketBeat Thu, 04 Sep 2025 21:28:23 GMT
 q1 eps estimate for crispr therapeutics raised by analyst  MarketBeat Thu, 04 Sep 2025 10:30:58 GMT
 invesco ltd. has $951,000 holdings in crispr therapeutics ag $crsp  MarketBeat Thu, 04 Sep 2025 07:23:11 GMT
 crispr therapeutics: don't rely solely on luck for success  AInvest Tue, 02 Sep 2025 12:58:02 GMT
 gene editing market to surpass usd 15.46 billion by 2032,  GlobeNewswire Tue, 02 Sep 2025 10:02:42 GMT
 CRISPR Therapeutics to Participate in Upcoming Investor Conferences  GlobeNewswire Tue, 02 Sep 2025 07:00:00 GMT
 zacks research has optimistic outlook of crsp q1 earnings  MarketBeat Tue, 02 Sep 2025 06:06:31 GMT
 zacks research issues optimistic outlook for crsp earnings  MarketBeat Tue, 02 Sep 2025 06:06:31 GMT
 crispr therapeutics ag earnings estimates up 3.5% in 30 days  AInvest Mon, 01 Sep 2025 14:13:03 GMT
 crispr-based gene editing market size to surpass usd 13.39  GlobeNewswire Mon, 01 Sep 2025 13:58:35 GMT

CRISPR Therapeutics AG
(NASDAQ:CRSP) 

CRSP stock logo

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technolo...

Founded: 1987
Full Time Employees: 458 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends